The primary objectives of the Analytic Core are to: ? provide access to high-quality, cost-effective laboratory testing for Affiliate Investigators (Als) ? provide consultation concerning laboratory testing ? develop, evaluate, and improve laboratory tests in human and animal specimens A secondary objective is to provide training for young investigators in method development and quality control. The Analytic Core of the NORC will continue to provide access to a wide array of comprehensive, state-of-the-art laboratory services for NORC Als in a highly cost-effective fashion. This is done by developing specialized tests performed directly by NORC technologists (direct services) and by facilitating laboratory services in various parts of the clinical laboratories in the Department of Laboratory Medicine and in other laboratories at the University of Washington (UW) that provide laboratory services (indirect services). By referring testing to various laboratories within the UW while handling logistics for those referrals, the Analytic Core provides comprehensive services in a manner that is as seamless as possible for Als, and broader in scope than would be cost-effective or possible for the Analytic Core working in isolation and performing only direct testing. The Core is a service facility, with the main mission to provide laboratory testing requested by Als. This involves responding to direct requests for assays as well as anticipating future needs and research directions. Faculty and technologists frequently consult with Als, direct research, and train young investigators using Analytic Core facilities. As has occurred during the past several years, the Core has adapted to the needs of the Als, has incorporated and is continuing to adapt to new technologies, and performs developmental research to set up and/or facilitate access to analyses. Training opportunities have helped two of our trainees advance into junior faculty positions where they continue basic science research in nutrition and inflammation. During the current funding cycle, a major focus ofthe Analytic Core has been development of novel targeted assays that use liquid chromatography-tandem mass spectrometry (LC-MS/MS). These efforts were mounted in response to the changing needs of the Als and have supported large studies in well-characterized populations. The Core has also continued its focus on high-quality assays for animal-derived specimens and continues its development of targeted assays for metabolites in tissues. To provide Als with access to cutting edge technology in discovery metabolomics and micro-RNA analyses, in response both to requests of current Als and anticipated future requests, we have developed a new Discovery Metabolomics Subcore. The major changes in the Core are: ? Development of high-throughput targeted proteomic and metabolomic assays ? Establishment of a Discovery Metabolomics Subcore

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZDK1-GRB-2 (M3))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Washington
United States
Zip Code
Wright, D R; Lozano, P; Dawson-Hahn, E et al. (2017) Parental optimism about childhood obesity-related disease risks. Int J Obes (Lond) 41:1467-1472
Han, Seung Jin; Boyko, Edward J; Fujimoto, Wilfred Y et al. (2017) Low Plasma Adiponectin Concentrations Predict Increases in Visceral Adiposity and Insulin Resistance. J Clin Endocrinol Metab 102:4626-4633
Den Hartigh, Laura J; Omer, Mohamed; Goodspeed, Leela et al. (2017) Adipocyte-Specific Deficiency of NADPH Oxidase 4 Delays the Onset of Insulin Resistance and Attenuates Adipose Tissue Inflammation in Obesity. Arterioscler Thromb Vasc Biol 37:466-475
Rubinow, Katya B; Henderson, Clark M; Robinson-Cohen, Cassianne et al. (2017) Kidney function is associated with an altered protein composition of high-density lipoprotein. Kidney Int 92:1526-1535
Morton, Gregory J; Muta, Kenjiro; Kaiyala, Karl J et al. (2017) Evidence That the Sympathetic Nervous System Elicits Rapid, Coordinated, and Reciprocal Adjustments of Insulin Secretion and Insulin Sensitivity During Cold Exposure. Diabetes 66:823-834
Anderson, Lindsey J; Tamayose, Jamie M; Garcia, Jose M (2017) Use of growth hormone, IGF-I, and insulin for anabolic purpose: Pharmacological basis, methods of detection, and adverse effects. Mol Cell Endocrinol :
Douglass, John D; Dorfman, Mauricio D; Thaler, Joshua P (2017) Glia: silent partners in energy homeostasis and obesity pathogenesis. Diabetologia 60:226-236
Dorfman, Mauricio D; Krull, Jordan E; Scarlett, Jarrad M et al. (2017) Deletion of Protein Kinase C ? in POMC Neurons Predisposes to Diet-Induced Obesity. Diabetes 66:920-934
Haenisch, Michael; Treuting, Piper M; Brabb, Thea et al. (2017) Pharmacological inhibition of ALDH1A enzymes suppresses weight gain in a mouse model of diet-induced obesity. Obes Res Clin Pract :
Wang, Shari; Goodspeed, Leela; Turk, Katherine E et al. (2017) Rosiglitazone Improves Insulin Resistance Mediated by 10,12 Conjugated Linoleic Acid in a Male Mouse Model of Metabolic Syndrome. Endocrinology 158:2848-2859

Showing the most recent 10 out of 564 publications